Parker Waichman LLP Headlines by Topic
Celebrex Lawsuit
Doctor Accused of Falsifying Drug Studies Pleads Guilty
Feb 23, 2010
| Parker Waichman LLP
Dr. Scott S. Reuben, former chief of acute pain at the Bay State Hospital in Springfield, Massachusetts, has pleaded guilty to one count of health...
Baystate Medical Center Subpoenaed Over Fake Drug Studies
Apr 8, 2009
| Parker Waichman LLP
The Baystate Medical Center has received a subpoena as part of a federal investigation into a doctor there who falsified 21 drug studies. ...
Researcher Faked Data for 21 Studies Involving Vioxx, Celebrex and Other Drugs
Mar 11, 2009
| Parker Waichman LLP
Medical journals have been asked to retract 21 studies that touted the benefits of Vioxx, Celebrex and other drugs. According to The Wall...
Vioxx, Celebrex, Other Painkillers Up Risks for Heart Failure, Heart Attack Patients
Nov 12, 2008
| Parker Waichman LLP
Vioxx, Celebrex, ibuprofen and other NSAID painkillers increase the chances that heart attack and heart failure patients will experience a second...
COX-2 Inhibitors More Likely to Raise Heart Risks Than Other NSAIDs
Nov 5, 2008
| Parker Waichman LLP
A new study that confirms the heart risks associated with a class of drugs called NSAIDs has found that the increased risk correlates to the specific...
Pfizer Announces Bextra, Celebrex Settlement
Oct 17, 2008
| Parker Waichman LLP
Pfizer has reached a tentative agreement to settle lawsuits involving its Bextra and Celebrex painkillers for $894 million. If it goes...
Ketek, Avandia Among Drugs Doctors Won't Take
Jun 23, 2008
| Parker Waichman LLP
When doctors were recently asked which commonly prescribed medications they would avoid, they came up with the following eight. Perhaps you...
Pfizer Negotiating Celebrex, Bextra Settlements
May 5, 2008
| Parker Waichman LLP
Celebrex and Bextra maker Pfizer Inc. has begun to settle injury claims against the painkillers. It is estimated that between 7,000 and 9,000...
Celebrex in High Doses Linked to Higher Stroke, Heart Attack Risks
Apr 1, 2008
| Parker Waichman LLP
Higher doses of Celebrex are a risky choice for patients with heart problems, a new study suggests. The results of this latest Celebrex study,...
Ex Pfizer Sales Manager Indicted For Allegedly Obstructing Off-label Marketing Probe
Mar 14, 2008
| Parker Waichman LLP
An investigation of Pfizer Inc. drug marketing efforts has resulted in charges being filed against a former Pfizer sales manager. The four...
Page 1/15 [first] [prev] 1 2 3 4 5 6 7 8 9 10 ... [next] [last]
